The independent data and safety monitoring committee paused the trial to evaluate safety ( cardiac arrhythmia , persistent acidosis , major vessel thrombosis and bleeding , and death in the neonatal intensive care unit [ NICU ] ) after the first 50 neonates were enrolled , then after every subsequent 25 neonates .